CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Venalafaxine hydrochloridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00167856
NCT00167856N/ACompleted
CompareCT.gov

Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury

US Department of Veterans Affairs·interventional·Posted Sep 14, 2005·Updated Mar 27, 2014

In Brief

A clinical study evaluating Venalafaxine hydrochloride for Neuropathic Pain and 2 related conditions. Completed, enrolled 16 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the pain-relieving effects of venlafaxine hydrochloride (Effexor) in chronic neuropathic (burning, shock-like, electric) pain after spinal cord injury (SCI). Although a number of medications have been used to treat SCI pain, no drug has been consistently helpful, and, therefore, many people with SCI continue to have difficult chronic pain. Venlafaxine is a new anti-depressant drug that has not been tested for use in SCI neuropathic pain, but has been helpful for other types of neuropathic pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuropathic Pain, Pain, Spinal Cord Injuries
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 14, 2005
Enrollment StartJun 1, 2005
Primary CompletionAug 1, 2007
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 20.8 years ago

Interventions

Venalafaxine hydrochloridedrug

Norepinephrine/Serotonin Reuptake Inhibitor (NSRI)